GRAM Ranked on the Inc. 5000 List for Fifth Consecutive Year
Grand River Aseptic Manufacturing (“GRAM”), a leader in parenteral contract development and manufacturing for the life science industry, specializing in biologics, small molecules, and vaccines, was recently ranked in the Inc. 5000 List for the fifth year in a row.
The Inc. 5000 represents a distinguished editorial award and celebration of innovation. The Inc. 5000 ranks companies by overall revenue growth over a three-year period and highlights the fastest-growing private companies in America.
Coming in at No. 1650 on the list, GRAM experienced an incredible 279% 3-year growth. Ranking No. 26 in Michigan and No. 55 in overall Manufacturing, GRAM proved their ability to generate success in a year that demanded far more than business as usual. Flexibility and resiliency were crucial to facing the challenges of 2020 and coming out on top.
A contributor to COVID vaccine production through Operation Warp Speed, GRAM navigated exponential growth in challenging times and has grown from 200 to 350 employees in under 18 months. GRAM achieved further acclaim in August, when Grand River Aseptic Manufacturing President and CEO, Tom Ross, was named EY Entrepreneur Of The Year® 2021 Michigan and Northwest Ohio Winner.
GRAM completed a ribbon-cutting ceremony for a new finishing and warehouse center this month, recognizing employee contributions to success over the past year. Occupying 110,000 square feet, GRAM’s finishing center is their largest facility yet and features four finishing rooms, Marchesini packaging line, Dividella packaging line, QC laboratory, coolers, freezers, and more.
To continue meeting increased industry demand, an expansion of GRAM’s large-scale aseptic fill/finish facility is also on the way. Opened in June 2020 and recognized by ISPE as a 2021 Facility of the Year Award winner, this added capacity will offer new technologies and further growth.
The expansion includes an additional Bausch+Ströbel Vial Filler with SKAN Isolator Technology, a duplicate of the current vial filler, which will effectively increase production capacity. GRAM is introducing top-of-the-line, innovative technology and expanding their portfolio with a new VarioSys syringe and vial filler, available in 2022.
GRAM provides advanced aseptic fill and finish services and produces high-quality parenteral therapeutics to various clients from clinical trials to commercialization. To view Grand River Aseptic Manufacturing in the full rankings, visit https://www.inc.com/inc5000/2021. For more information or to contact Grand River Aseptic Manufacturing, please visit https://www.grandriverasepticmfg.com/ or call (616) 678-2400.
About Grand River Aseptic Manufacturing, Inc.
Grand River Aseptic Manufacturing, Inc. (“GRAM”), a parenteral contract development and manufacturing organization, delivers customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing, and regulatory filing.